×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ONC – beone medicines ltd. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ONC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
06:01 am
onc
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
Neutral
Report
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/18
06:33 am
onc
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma [Yahoo! Finance]
Low
Report
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma [Yahoo! Finance]
12/18
06:00 am
onc
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma
Low
Report
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma
12/17
01:07 pm
onc
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/8
08:00 am
onc
BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
Low
Report
BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
12/7
06:00 pm
onc
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
Low
Report
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
11/26
06:00 am
onc
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Low
Report
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
11/24
09:04 am
onc
BeOne Medicines (NASDAQ:ONC) was given a new $400.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
BeOne Medicines (NASDAQ:ONC) was given a new $400.00 price target on by analysts at Truist Financial Corporation.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
06:00 am
onc
beone medicines ltd. - american depositary shares
BEAT
Report
3.5%
beone medicines ltd. - american depositary shares
8/6/2025
06:00 am
onc
beone medicines ltd. - american depositary shares
BEAT
Report
-2.3%
beone medicines ltd. - american depositary shares
5/7/2025
06:00 am
onc
beone medicines ltd. - american depositary shares
BEAT
Report
-1.3%
beone medicines ltd. - american depositary shares
2/27/2025
06:00 am
onc
beone medicines ltd. - american depositary shares
MISS
Report
4.7%
beone medicines ltd. - american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
04:48 pm
onc
Form 4 BeOne Medicines Ltd. For: Dec 15 Filed by: OYLER JOHN
Low
Report
Form 4 BeOne Medicines Ltd. For: Dec 15 Filed by: OYLER JOHN
12/12
04:56 pm
onc
Form 4 BeOne Medicines Ltd. For: Dec 10 Filed by: Lee Chan Henry
Medium
Report
Form 4 BeOne Medicines Ltd. For: Dec 10 Filed by: Lee Chan Henry
12/1
04:58 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 26 Filed by: Sanders Corazon (Corsee) D.
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 26 Filed by: Sanders Corazon (Corsee) D.
11/19
04:58 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 17 Filed by: Wu Xiaobin
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 17 Filed by: Wu Xiaobin
11/14
05:35 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 12 Filed by: Wu Xiaobin
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 12 Filed by: Wu Xiaobin
11/14
05:28 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 12 Filed by: Lee Chan Henry
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 12 Filed by: Lee Chan Henry
11/12
04:47 pm
onc
Form 4 BeOne Medicines Ltd. For: Nov 07 Filed by: Wang Xiaodong
Low
Report
Form 4 BeOne Medicines Ltd. For: Nov 07 Filed by: Wang Xiaodong
10/10
04:57 pm
onc
Form 4 BeOne Medicines Ltd. For: Oct 08 Filed by: Lee Chan Henry
Low
Report
Form 4 BeOne Medicines Ltd. For: Oct 08 Filed by: Lee Chan Henry
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: